Tag Archive | "big pharma"

Pfizer creates breaking news with Allergan purchase

Tags: , , ,

US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history. Read the full story

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

Tags: , , , ,

An interview with Richard Brudnick, Senior VP, Corporate Development, Biogen

De-risking has evolved from literature searches to the cultivation of many wide-ranging relationships throughout the life sciences strata, according to Richard Brudnick, Senior VP, Corporate Development at Biogen. In a recent interview, Brudnick outlined key strategies to accessing innovation and “de-risking” risk through collaboration. Read the full story

Bayer and Isis in ISIS-FXIRx licensing pact

Tags: , ,

Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals on ISIS-FXIRx Read the full story

Roche and 4D Molecular partner for AAV vectors

Tags: , ,

4D Molecular Therapeutics announced a collaboration and license agreement with Roche to discover and develop optimized next-generation AAV vectors Read the full story

Celgene acquires Quanticel Pharmaceuticals

Tags: , , ,

Celgene and Quanticel Pharmaceuticals announced a definitive share purchase agreement under which Celgene will acquire Quanticel Read the full story

AstraZeneca and Innate Pharma in IPH2201 deal

Tags: , ,

Innate Pharma has signed a co-development and commercialization agreement with AstraZeneca Read the full story

Celgene and AstraZeneca in MEDI4736 pact

Tags: , ,

Celgene has entered into a strategic collaboration with MedImmune to develop and commercialize an anti-PD-L1 inhibitor, MEDI4736, for hematologic malignancies Read the full story

Teva bids to acquire Mylan as Perrigo rejects approach

Tags: , , ,

Teva Pharmaceutical announced a proposal to acquire all of the outstanding shares of Mylan in a transaction valued at $40 billion Read the full story

Roche and Curevac partner for IDO1 and TDO inhibitors

Tags: , ,

Curadev Pharma has entered into a research collaboration and license agreement with Roche for development and commercialization of IDO1 and TDO inhibitors Read the full story

Merck and Tetralogic in solid tumor clinical pact

Tags: , ,

TetraLogic and Merck will collaborate on a Phase 1 study Read the full story